ArborGen Appoints Richard I. Eisenstadt as Chief Financial Officer
Accomplished finance veteran will help chart the company’s path toward
continued global expansion and further commercialization of its forestry
RIDGEVILLE, S.C. -- January 8, 2013
ArborGen, the world leader in the development and commercialization of
technologies that improve the productivity of trees, today announced that
Richard I. Eisenstadt has been named chief financial officer (CFO) effective
immediately. Eisenstadt brings an extensive track record of finance and
business experience and a broad understanding of funding growth companies. As
ArborGen’s new CFO, Eisenstadt will be responsible for the company’s finance,
treasury and investor relations functions and serve as an executive business
partner to Andrew Baum, president and chief executive officer of ArborGen.
“As the principal financial and commercial strategist for ArborGen, Richard
brings outstanding financial and analytical knowledge, strong leadership
skills and an execution-based management style,” said Baum. “Richard’s wealth
of experience will complement the current management team’s expertise in
assessing and implementing growth strategies as we execute our vision and
expand our global commercial operations.”
Eisenstadt has over thirty years of finance leadership experience in the
healthcare, life sciences and emerging technology industries. For the previous
nine years, he served as the CFO of Tranzyme Pharma (NASDAQ: TZYM), where he
raised over $150 million in equity and debt, including the completion of the
company’s Initial Public Offering (IPO). Prior to joining Tranzyme Pharma, he
served as the Director of Finance for Cogent Neuroscience, Inc. He spent over
eleven years with Nimbus CD International where he served as Director of
Strategic Planning and Development and Treasury Manager, and where he was
involved in an IPO and a $260 million sale and merger of the company.
Eisenstadt has a BA in Economics from University of North Carolina at Chapel
Hill and he received his MBA from James Madison University.
ArborGen is revolutionizing productivity in commercial forestry. ArborGen is
the largest global supplier of seedling products and a leading provider of
improved technologies to the commercial forest industry. Through innovations
in conventional breeding, improved genetics and emerging biotechnology
advances, ArborGen is developing high-value products that significantly
improve the economic returns and productivity of a given acre of land. These
products enable ArborGen’s customers to grow trees that yield more wood per
acre with greater consistency and quality in a shorter period of time.
ArborGen’s work is improving the sustainability of working forests while
helping to meet the world’s growing need for wood, fiber and energy. For more
information, please visit www.arborgen.com.
Cathy O. Quinn, 843-851-4143
Manager, Communications and Public Affairs
Press spacebar to pause and continue. Press esc to stop.